Alar Pharmaceuticals Inc. (TPEX:6785)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
172.00
-4.00 (-2.27%)
Mar 26, 2026, 1:30 PM CST
Market Cap11.49B +14.7%
Revenue (ttm)2.75M -52.7%
Net Income-79.68M
EPS-1.19
Shares Out66.80M
PE Ration/a
Forward PEn/a
Dividend0.25 (0.14%)
Ex-Dividend DateJun 10, 2025
Volume70,647
Average Volume254,269
Open176.00
Previous Close176.00
Day's Range172.00 - 178.00
52-Week Range108.50 - 317.00
Beta0.09
RSI36.41
Earnings DateMay 8, 2026

About Alar Pharmaceuticals

Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan. [Read more]

Sector Healthcare
Founded 2016
Employees 27
Stock Exchange Taipei Exchange
Ticker Symbol 6785
Full Company Profile

Financial Performance

Financial Statements